EUDA Health Holdings Ltd. Files July 2024 6-K Report
Ticker: EUDAW · Form: 6-K · Filed: Jul 29, 2024 · CIK: 1847846
Sentiment: neutral
Topics: reporting, corporate-update, foreign-private-issuer
TL;DR
EUDA Health Holdings (formerly 8i Acquisition 2 Corp.) filed its July 6-K, confirming 20-F annual reports.
AI Summary
EUDA Health Holdings Ltd. filed a Form 6-K on July 29, 2024, reporting for the month of July 2024. The company, formerly known as 8i Acquisition 2 Corp., is a foreign private issuer based in Singapore. The filing indicates it will file annual reports under Form 20-F.
Why It Matters
This filing provides an update on EUDA Health Holdings Ltd.'s reporting status and corporate history, which is important for investors tracking the company's compliance and evolution.
Risk Assessment
Risk Level: low — This is a routine reporting form (6-K) that does not contain significant new financial or operational information.
Key Players & Entities
- EUDA Health Holdings Ltd (company) — Registrant
- 8i Acquisition 2 Corp. (company) — Former company name
- July 2024 (date) — Reporting period
- 20240729 (date) — Filing date
- Form 20-F (document) — Annual report form
- Form 6-K (document) — Report type
FAQ
What is the primary purpose of this Form 6-K filing?
The Form 6-K is a Report of Foreign Private Issuer filed pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, for the month of July 2024.
What was EUDA Health Holdings Ltd.'s former name?
EUDA Health Holdings Ltd.'s former name was 8i Acquisition 2 Corp., with a date of name change on February 24, 2021.
Where is EUDA Health Holdings Ltd. located?
The company's principal executive offices are located at 1 Pemimpin Drive #12-07, One Pemimpin, Singapore 576151.
Which form does the registrant indicate it will file for annual reports?
The registrant indicates it files or will file annual reports under cover of Form 20-F.
What is the Commission File Number for this filing?
The Commission File Number for this filing is 001-40678.
Filing Stats: 709 words · 3 min read · ~2 pages · Grade level 17.8 · Accepted 2024-07-29 08:30:41
Key Financial Figures
- $15.0 million — uo;), for an aggregate consideration of $15.0 million paid in the form of 8,571,428 shares (&
- $1.75 — nsideration Shares”) based on the $1.75 per share price pursuant to a Share Pur
Filing Documents
- form6-k.htm (6-K) — 20KB
- ex10-1.htm (EX-10.1) — 8KB
- ex10-1_001.jpg (GRAPHIC) — 452KB
- ex10-1_002.jpg (GRAPHIC) — 2186KB
- ex10-1_003.jpg (GRAPHIC) — 1332KB
- ex10-1_004.jpg (GRAPHIC) — 497KB
- ex10-1_005.jpg (GRAPHIC) — 426KB
- ex10-1_006.jpg (GRAPHIC) — 508KB
- ex10-1_007.jpg (GRAPHIC) — 553KB
- ex10-1_008.jpg (GRAPHIC) — 560KB
- ex10-1_009.jpg (GRAPHIC) — 519KB
- 0001493152-24-029378.txt ( ) — 9707KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized. Dated: July 29, 2024 EUDA Health Holdings Limited By: /s/ Wei Wen Kelvin Chen Name: Wei Wen Kelvin Chen Title: Chief Executive Officer